| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |